SenesTech (NASDAQ:SNES) Coverage Initiated at StockNews.com

Investment analysts at StockNews.com began coverage on shares of SenesTech (NASDAQ:SNES) in a research note issued to investors on Friday. The firm set a “sell” rating on the stock.

Separately, HC Wainwright boosted their target price on shares of SenesTech from $3.50 to $10.00 and gave the company a “buy” rating in a research note on Thursday, December 12th.

SenesTech Stock Performance

NASDAQ SNES opened at $1.59 on Friday. The firm has a market capitalization of $2.78 million, a P/E ratio of -0.16 and a beta of -0.03. The stock has a 50-day simple moving average of $2.52 and a two-hundred day simple moving average of $2.69. The company has a debt-to-equity ratio of 0.05, a quick ratio of 4.92 and a current ratio of 6.32. SenesTech has a fifty-two week low of $1.30 and a fifty-two week high of $9.80.

SenesTech (NASDAQ:SNES) last announced its quarterly earnings results on Wednesday, March 12th. The company reported ($1.22) earnings per share for the quarter, beating the consensus estimate of ($1.50) by $0.28. SenesTech had a negative return on equity of 150.33% and a negative net margin of 403.51%. The company had revenue of $0.50 million during the quarter, compared to analysts’ expectations of $0.71 million. On average, equities analysts forecast that SenesTech will post -10.22 earnings per share for the current year.

About SenesTech

SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.